{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T14:36:06Z","timestamp":1721054166892},"reference-count":27,"publisher":"Japanese Society of Veterinary Science","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1292\/jvms.21-0217","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T22:10:54Z","timestamp":1634854254000},"page":"1885-1890","source":"Crossref","is-referenced-by-count":2,"title":["Detection of indoleamine 2,3-dioxygenase 1-expressing cells in canine normal and tumor tissues"],"prefix":"10.1292","volume":"83","author":[{"given":"Namiko","family":"IKEDA","sequence":"first","affiliation":[{"name":"Laboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"KATO","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"TSUBOI","sequence":"additional","affiliation":[{"name":"Veterinary Medical Center, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"YOSHITAKE","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"ETO","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"YOSHIMOTO","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"SHINADA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"KAMOTO","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"HASHIMOTO","sequence":"additional","affiliation":[{"name":"Veterinary Medical Center, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousuke","family":"TAKAHASHI","sequence":"additional","affiliation":[{"name":"Veterinary Medical Center, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"CHAMBERS","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"UCHIDA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"NISHIMURA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"NAKAGAWA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Beatty, G. L., O\u2019Dwyer, P. J., Clark, J., Shi, J. G., Bowman, K. J., Scherle, P. A., Newton, R. C., Schaub, R., Maleski, J., Leopold, L. and Gajewski, T. F. 2017. First-in-human phase I study of the oral inhibitor of indoleamine 2,3-dioxygenase-1 epacadostat (INCB024360) in patients with advanced solid malignancies. Clin. Cancer Res. 23: 3269\u20133276.","DOI":"10.1158\/1078-0432.CCR-16-2272"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Brenk, M., Scheler, M., Koch, S., Neumann, J., Takikawa, O., H\u00e4cker, G., Bieber, T. and von Bubnoff, D. 2009. Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells. J. Immunol. 183: 145\u2013154.","DOI":"10.4049\/jimmunol.0803277"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chen, W., Liang, X., Peterson, A. J., Munn, D. H. and Blazar, B. R. 2008. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J. Immunol. 181: 5396\u20135404.","DOI":"10.4049\/jimmunol.181.8.5396"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dai, X. and Zhu, B. T. 2010. Indoleamine 2,3-dioxygenase tissue distribution and cellular localization in mice: implications for its biological functions. J. Histochem. Cytochem. 58: 17\u201328.","DOI":"10.1369\/jhc.2009.953604"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., Santamaria, P., Fioretti, M. C. and Puccetti, P. 2006. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J. Immunol. 176: 6752\u20136761.","DOI":"10.4049\/jimmunol.176.11.6752"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gangadhar, T. C., Schneider, B. J., Bauer, T. M., Wasser, J. S., Spira, A. I., Patel, S. P., Balmanoukian, A. S., Bauml, J., Schmidt, E. V., Zhao, Y., Jones, M. M. and Tarhini, A. A. 2017. Efficacy and safety of epacadostat plus pembrolizumab treatment of NSCLC: Preliminary phase I\/II results of ECHO-202\/KEYNOTE-037. J. Clin. Orthod. 35: 9014\u20139014.","DOI":"10.1200\/JCO.2017.35.15_suppl.9014"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hennequart, M., Pilotte, L., Cane, S., Hoffmann, D., Stroobant, V., Plaen, E. and Van den Eynde, B. J. 2017. Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance. Cancer Immunol. Res. 5: 695\u2013709.","DOI":"10.1158\/2326-6066.CIR-16-0400"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Igase, M., Nemoto, Y., Itamoto, K., Tani, K., Nakaichi, M., Sakurai, M., Sakai, Y., Noguchi, S., Kato, M., Tsukui, T. and Mizuno, T. 2020. A pilot clinical study of the therapeutic antibody against canine PD-1 for advanced spontaneous cancers in dogs. Sci. Rep. 10: 18311.","DOI":"10.1038\/s41598-020-75533-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Khan, K. N., Knapp, D. W., Denicola, D. B. and Harris, R. K. 2000. Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs. Am. J. Vet. Res. 61: 478\u2013481.","DOI":"10.2460\/ajvr.2000.61.478"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Litzenburger, U. M., Opitz, C. A., Sahm, F., Rauschenbach, K. J., Trump, S., Winter, M., Ott, M., Ochs, K., Lutz, C., Liu, X., Anastasov, N., Lehmann, I., H\u00f6fer, T., von Deimling, A., Wick, W. and Platten, M. 2014. Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR. Oncotarget 5: 1038\u20131051.","DOI":"10.18632\/oncotarget.1637"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Liu, X., Shin, N., Koblish, H. K., Yang, G., Wang, Q., Wang, K., Leffet, L., Hansbury, M. J., Thomas, B., Rupar, M., Waeltz, P., Bowman, K. J., Polam, P., Sparks, R. B., Yue, E. W., Li, Y., Wynn, R., Fridman, J. S., Burn, T. C., Combs, A. P., Newton, R. C. and Scherle, P. A. 2010. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity. Blood 115: 3520\u20133530.","DOI":"10.1182\/blood-2009-09-246124"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Luke, J. J., Tabernero, J., Joshua, A., Desai, J., Varga, A. I., Moreno, V., Gomez-Roca, C. A., Markman, B., De Braud, F. G., Patel, S. P., Carlino, M. S., Siu, L. L., Curigliano, G., Liu, Z., Ishii, Y., Wind-Rotolo, M., Basciano, P. A., Azrilevich, A. and Gelmon, K. A. 2019. BMS-986205, an indoleamine 2, 3-dioxygenase 1 inhibitor (IDO1i), in combination with nivolumab (nivo): Updated safety across all tumor cohorts and efficacy in advanced bladder cancer (advBC). J. Clin. Orthod. 37: 358.","DOI":"10.1200\/JCO.2019.37.7_suppl.358"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Maekawa, N., Konnai, S., Nishimura, M., Kagawa, Y., Takagi, S., Hosoya, K., Ohta, H., Kim, S., Okagawa, T., Izumi, Y., Deguchi, T., Kato, Y., Yamamoto, S., Yamamoto, K., Toda, M., Nakajima, C., Suzuki, Y., Murata, S. and Ohashi, K. 2021. PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma. npj Precision Oncology. 5: 1\u20139.","DOI":"10.1038\/s41698-021-00147-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Maekawa, N., Konnai, S., Takagi, S., Kagawa, Y., Okagawa, T., Nishimori, A., Ikebuchi, R., Izumi, Y., Deguchi, T., Nakajima, C., Kato, Y., Yamamoto, K., Uemura, H., Suzuki, Y., Murata, S. and Ohashi, K. 2017. A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma. Sci. Rep. 7: 8951.","DOI":"10.1038\/s41598-017-09444-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Meireson, A., Devos, M. and Brochez, L. 2020. IDO expression in cancer: different compartment, different functionality? Front. Immunol. 11: 531491.","DOI":"10.3389\/fimmu.2020.531491"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mellor, A. L. and Munn, D. H. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762\u2013774.","DOI":"10.1038\/nri1457"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mezrich, J. D., Fechner, J. H., Zhang, X., Johnson, B. P., Burlingham, W. J. and Bradfield, C. A. 2010. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 185: 3190\u20133198.","DOI":"10.4049\/jimmunol.0903670"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mitchell, T. C., Hamid, O., Smith, D. C., Bauer, T. M., Wasser, J. S., Olszanski, A. J., Luke, J. J., Balmanoukian, A. S., Schmidt, E. V., Zhao, Y., Gong, X., Maleski, J., Leopold, L. and Gajewski, T. F. 2018. Epacadostat Plus Pembrolizumab in patients with advanced solid tumors: phase i results from a multicenter, open-label phase I\/II Trial (ECHO-202\/KEYNOTE-037). J. Clin. Oncol. 36: 3223\u20133230.","DOI":"10.1200\/JCO.2018.78.9602"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Monjazeb, A. M., Kent, M. S., Grossenbacher, S. K., Mall, C., Zamora, A. E., Mirsoian, A., Chen, M., Kol, A., Shiao, S. L., Reddy, A., Perks, J. R., T N Culp, W., Sparger, E. E., Canter, R. J., Sckisel, G. D. and Murphy, W. J. 2016. Blocking indolamine-2,3-dioxygenase rebound immune suppression boosts antitumor effects of radio-immunotherapy in murine models and spontaneous canine malignancies. Clin. Cancer Res. 22: 4328\u20134340.","DOI":"10.1158\/1078-0432.CCR-15-3026"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C. and Mellor, A. L. 1998. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191\u20131193.","DOI":"10.1126\/science.281.5380.1191"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A. and Mellor, A. L. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189: 1363\u20131372.","DOI":"10.1084\/jem.189.9.1363"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Porcellato, I., Brachelente, C., Cappelli, K., Menchetti, L., Silvestri, S., Sforna, M., Mecocci, S., Iussich, S., Leonardi, L. and Mechelli, L. 2021. FoxP3, CTLA-4, and IDO in canine melanocytic tumors. Vet. Pathol. 58: 42\u201352.","DOI":"10.1177\/0300985820960131"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Porcellato, I., Brachelente, C., De Paolis, L., Menchetti, L., Silvestri, S., Sforna, M., Vichi, G., Iussich, S. and Mechelli, L. 2019. FoxP3 and IDO in canine melanocytic tumors. Vet. Pathol. 56: 189\u2013199.","DOI":"10.1177\/0300985818808530"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Soliman, H., Rawal, B., Fulp, J., Lee, J. H., Lopez, A., Bui, M. M., Khalil, F., Antonia, S., Yfantis, H. G., Lee, D. H., Dorsey, T. H. and Ambs, S. 2013. Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry. Cancer Immunol. Immunother. 62: 829\u2013837.","DOI":"10.1007\/s00262-013-1393-y"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Spranger, S., Koblish, H. K., Horton, B., Scherle, P. A., Newton, R. and Gajewski, T. F. 2014. Mechanism of tumor rejection with doublets of CTLA-4, PD-1\/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment. J. Immunother. Cancer 2: 3.","DOI":"10.1186\/2051-1426-2-3"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Th\u00e9ate, I., van Baren, N., Pilotte, L., Moulin, P., Larrieu, P., Renauld, J. C., Herv\u00e9, C., Gutierrez-Roelens, I., Marbaix, E., Sempoux, C. and Van den Eynde, B. J. 2015. Extensive profiling of the expression of the indoleamine 2,3-dioxygenase 1 protein in normal and tumoral human tissues. Cancer Immunol. Res. 3: 161\u2013172.","DOI":"10.1158\/2326-6066.CIR-14-0137"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yoshitake, R., Saeki, K., Eto, S., Shinada, M., Nakano, R., Sugiya, H., Endo, Y., Fujita, N., Nishimura, R. and Nakagawa, T. 2020. Aberrant expression of the COX2\/PGE<sub>2<\/sub> axis is induced by activation of the RAF\/MEK\/ERK pathway in BRAF<sup>V595E<\/sup> canine urothelial carcinoma. Sci. Rep. 10: 7826.","DOI":"10.1038\/s41598-020-64832-5"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/83\/12\/83_21-0217\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T03:58:35Z","timestamp":1638590315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/83\/12\/83_21-0217\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.21-0217","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"21-0217"}}